Literature DB >> 21626678

5q14.3 neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C.

Christopher W Carr1, Holly H Zimmerman, Christa Lese Martin, Miikka Vikkula, Adam C Byrd, Omar A Abdul-Rahman.   

Abstract

Haploinsufficiency of RASA1, located on chromosome 5q14.3, has been identified as the etiology underlying the disorder capillary malformation-arteriovenous malformation (CM-AVM). Recently, haploinsufficiency of MEF2C, located 1.33 Mb distal to RASA1 on chromosome 5q14.3, has been implicated as the genetic etiology underlying a complex array of deficits including mental retardation, hypotonia, absent speech, seizures, and brain anomalies. Here we report a patient who is haploinsufficient in both RASA1 and MEF2C who presents with dermatologic and neurologic abnormalities that constitute a 5q14.3 neurocutaneous syndrome. This finding highlights the need to assess for CM-AVM in patients with neurologic features consistent with MEF2C haploinsufficiency, and vice versa.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626678     DOI: 10.1002/ajmg.a.34059

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  Genome-wide analyses identify common variants associated with macular telangiectasia type 2.

Authors:  Thomas S Scerri; Anna Quaglieri; Carolyn Cai; Jana Zernant; Nori Matsunami; Lisa Baird; Lea Scheppke; Roberto Bonelli; Lawrence A Yannuzzi; Martin Friedlander; Catherine A Egan; Marcus Fruttiger; Mark Leppert; Rando Allikmets; Melanie Bahlo
Journal:  Nat Genet       Date:  2017-02-27       Impact factor: 38.330

2.  MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways.

Authors:  Alex R Paciorkowski; Ryan N Traylor; Jill A Rosenfeld; Jacqueline M Hoover; Catharine J Harris; Susan Winter; Yves Lacassie; Martin Bialer; Allen N Lamb; Roger A Schultz; Elizabeth Berry-Kravis; Brenda E Porter; Marni Falk; Anu Venkat; Rena J Vanzo; Julie S Cohen; Ali Fatemi; William B Dobyns; Lisa G Shaffer; Blake C Ballif; Eric D Marsh
Journal:  Neurogenetics       Date:  2013-02-07       Impact factor: 2.660

Review 3.  Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements.

Authors:  Irena Vrečar; Josie Innes; Elizabeth A Jones; Helen Kingston; William Reardon; Bronwyn Kerr; Jill Clayton-Smith; Sofia Douzgou
Journal:  J Pediatr Genet       Date:  2017-04-12

4.  The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome.

Authors:  M Zweier; A Rauch
Journal:  Mol Syndromol       Date:  2012-04-16

5.  Postnatal Loss of Mef2c Results in Dissociation of Effects on Synapse Number and Learning and Memory.

Authors:  Megumi Adachi; Pei-Yi Lin; Heena Pranav; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2015-10-08       Impact factor: 13.382

6.  Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation.

Authors:  Whitney L Wooderchak-Donahue; Peter Johnson; Jamie McDonald; Francine Blei; Alejandro Berenstein; Michelle Sorscher; Jennifer Mayer; Angela E Scheuerle; Tracey Lewis; J Fredrik Grimmer; Gresham T Richter; Marcie A Steeves; Angela E Lin; David A Stevenson; Pinar Bayrak-Toydemir
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

Review 7.  EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease.

Authors:  Xue Zeng; Ava Hunt; Sheng Chih Jin; Daniel Duran; Jonathan Gaillard; Kristopher T Kahle
Journal:  Trends Mol Med       Date:  2019-02-25       Impact factor: 11.951

8.  NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

Authors:  Shichun Tu; Mohd Waseem Akhtar; Rosa Maria Escorihuela; Alejandro Amador-Arjona; Vivek Swarup; James Parker; Jeffrey D Zaremba; Timothy Holland; Neha Bansal; Daniel R Holohan; Kevin Lopez; Scott D Ryan; Shing Fai Chan; Li Yan; Xiaofei Zhang; Xiayu Huang; Abdullah Sultan; Scott R McKercher; Rajesh Ambasudhan; Huaxi Xu; Yuqiang Wang; Daniel H Geschwind; Amanda J Roberts; Alexey V Terskikh; Robert A Rissman; Eliezer Masliah; Stuart A Lipton; Nobuki Nakanishi
Journal:  Nat Commun       Date:  2017-11-14       Impact factor: 14.919

9.  Genetic syndromes with vascular malformations - update on molecular background and diagnostics.

Authors:  Adam Ustaszewski; Joanna Janowska-Głowacka; Katarzyna Wołyńska; Anna Pietrzak; Magdalena Badura-Stronka
Journal:  Arch Med Sci       Date:  2020-02-25       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.